New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 30, 2014
16:09 EDTBLUEbluebird bio acquires Precision Genome Engineering
bluebird bio announced the acquisition of Precision Genome Engineering, or Pregenen, a privately held biotechnology company headquartered in Seattle, Washington. Pregenen is a leader in the development of gene editing and cell signaling technologies with a broad range of potential therapeutic applications. Under the terms of the agreement, bluebird bio issued the former stakeholders of Pregenen 408,667 shares of bluebird common stock at closing, and paid or assumed approximately $4.9M of current liabilities of Pregenen and its stakeholders. The former stakeholders of Pregenen are also eligible to receive up to an additional $15M in cash upon the achievement of certain preclinical milestones as well as $20.1M in cash upon achievement of certain clinical milestones and $99.9M in cash upon the achievement of certain commercial milestones with respect to product candidates identified using Pregenenís technology.
News For BLUE From The Last 14 Days
Check below for free stories on BLUE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 15, 2014
07:26 EDTBLUEPiper Jaffray to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use